Date Title Description PDF
29 Sep 2025 On corporate transactions: mergers, acquisitions and others ROVI announces the acquisition of an injectable drug product manufacturing site in Phoenix, Arizona (USA) Download
29 Sep 2025 On corporate transactions: mergers, acquisitions and others The Company releases the presentation related to the acquisition of an injectable drug product manufacturing site in Phoenix, Arizona (USA) Download
24 Jul 2025 On P&L The Company releases the press release related to the first half of 2025 financial results Download
24 Jul 2025 On P&L The Company releases the first half 2025 financial results presentation Download
25 Mar 2025 On business and financial situation The Company releases the presentation related to its strategy update because of its 2025 Capital Markets Day Download

Pages

Date Title Description PDF
01 Sep 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 25 August and 31 August 2023 Download
25 Aug 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 18 August and 24 August 2023 Download
18 Aug 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 11 August and 17 August 2023 Download
11 Aug 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 3 August and 10 August 2023 Download
03 Aug 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 26 July 2023 and 2 August 2023 Download

Pages

Date Title Description PDF
05 Oct 2017 Contratos de liquidez y contrapartida Liquidity contract: modification of transactions conducted from 11 July to 30 September 2017. Download
03 Oct 2017 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted from 11 July to 30 September 2017   Download
07 Sep 2017 Otros sobre negocio y situación financiera The Company informs that commences the enoxaparin biosimilar marketing in Germany Download
26 Jul 2017 Información sobre resultados ROVI releases the presentation related to the 2017 first half results Download
26 Jul 2017 Información sobre resultados ROVI releases the presentation related to the 2017 first half results Download

Pages